<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "journalpublishing.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="2.0" xml:lang="en" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">JMIR Form Res</journal-id><journal-id journal-id-type="publisher-id">formative</journal-id><journal-id journal-id-type="index">27</journal-id><journal-title>JMIR Formative Research</journal-title><abbrev-journal-title>JMIR Form Res</abbrev-journal-title><issn pub-type="epub">2561-326X</issn><publisher><publisher-name>JMIR Publications</publisher-name><publisher-loc>Toronto, Canada</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">v9i1e67401</article-id><article-id pub-id-type="doi">10.2196/67401</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>The Development of a Patient-Centered Digital Health Care Technology for Young Adults in Opioid Use Disorder Treatment: Qualitative Study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Alexander</surname><given-names>Karen</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Scialanca</surname><given-names>Madison</given-names></name><degrees>MPH</degrees><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1"><institution>Friends Research Institute</institution><addr-line>1040 Park Avenue, Suite 103</addr-line><addr-line>Philadelphia</addr-line><addr-line>PA</addr-line><country>United States</country></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Mavragani</surname><given-names>Amaryllis</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name name-style="western"><surname>Lunze</surname><given-names>Karsten</given-names></name></contrib><contrib contrib-type="reviewer"><name name-style="western"><surname>Dainty</surname><given-names>Katie</given-names></name></contrib><contrib contrib-type="reviewer"><name name-style="western"><surname>Yoshiuchi</surname><given-names>Kazuhiro</given-names></name></contrib></contrib-group><author-notes><corresp>Correspondence to Karen Alexander, PhD, Friends Research Institute, 1040 Park Avenue, Suite 103, Philadelphia, PA, 21201, United States, 1 410 837 3977; <email>kalexander@friendsresearch.org</email></corresp></author-notes><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>23</day><month>9</month><year>2025</year></pub-date><volume>9</volume><elocation-id>e67401</elocation-id><history><date date-type="received"><day>10</day><month>10</month><year>2024</year></date><date date-type="rev-recd"><day>04</day><month>09</month><year>2025</year></date><date date-type="accepted"><day>05</day><month>09</month><year>2025</year></date></history><copyright-statement>&#x00A9; Karen Alexander, Madison Scialanca. Originally published in JMIR Formative Research (<ext-link ext-link-type="uri" xlink:href="https://formative.jmir.org">https://formative.jmir.org</ext-link>), 23.9.2025. </copyright-statement><copyright-year>2025</copyright-year><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on <ext-link ext-link-type="uri" xlink:href="https://formative.jmir.org">https://formative.jmir.org</ext-link>, as well as this copyright and license information must be included.</p></license><self-uri xlink:type="simple" xlink:href="https://formative.jmir.org/2025/1/e67401"/><abstract><sec><title>Background</title><p>Young adults, defined as individuals between the ages of 18 and 29 years, drop out of opioid use disorder (OUD) treatment more often than older adults. Premature treatment drop-out substantially increases fatal overdose risk. Self-monitoring through text messaging has been researched extensively among people with OUD to identify drop-out risk factors. Self-monitoring could potentially improve methadone treatment engagement among young adults, who are a population that is both hard to reach and more likely to use technology compared to older adults. Self-monitoring can increase risk factor awareness and help patients and counselors develop targeted coping strategies and treatment plans. However, embedding a discussion of risk factor information into existing counseling sessions has been limited and may offer a promising opportunity to improve engagement among young adults.</p></sec><sec><title>Objective</title><p>This pilot proof-of-concept study examined the implementation of self-monitoring intervention, AWARE (Awareness and Response to the Environment), designed to bring attention to treatment drop-out risk factors among young adults and create discussion about risk factors with their existing treatment counselor.</p></sec><sec sec-type="methods"><title>Methods</title><p>In this formative research, a convenience sample (N=8) of young adults (n=3, 38%) in methadone treatment, their counselors (n=3, 38%), and clinic leadership (n=2, 25%) were recruited from an opioid treatment program after referral from treatment staff. Participants were interviewed to obtain feedback as AWARE was developed. In semistructured interviews, perspectives regarding barriers to treatment for young adults and AWARE utility were obtained. Concurrently, 3 dyads of young adults (n=3, 38%) and counselors (n=3, 38%) piloted the intervention daily for 4 weeks.</p></sec><sec sec-type="results"><title>Results</title><p>The 3 consented young adults with OUD participants (n=2, 67% female; n=2, 67% Latino/a) were sent daily surveys for 28 days (53% overall completion rate). Young adults and counselors found AWARE relevant to their treatment experience and acceptable to complete over 4 weeks. The most reported daily stressors included concerns about the health and well-being of a family member, challenges with staying organized, and feeling overwhelmed by responsibilities without adequate support. In qualitative interviews, counselors and clinic leadership reported that AWARE presented a relevant, new way to engage young adults daily, in addition to weekly counseling sessions. Young adults felt that prompts sent by AWARE offered a type of social support they lacked, like &#x201C;someone checking in on them.&#x201D;</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>Overall, young adult and counselor participants were able to engage in AWARE in a busy clinic environment, and participants and clinic leadership found it valuable. By addressing common stressors and providing a sense of social connection, AWARE may help fill a gap in support between counseling sessions. However, the study was limited by the small number of young adults engaging in methadone treatment. Further research is needed to refine the measures and methods of AWARE and evaluate its effectiveness.</p></sec></abstract><kwd-group><kwd>ecological momentary assessment</kwd><kwd>treatment barriers</kwd><kwd>opioid use disorder</kwd><kwd>opioid treatment programs</kwd><kwd>qualitative study</kwd><kwd>patient-centered</kwd><kwd>digital health care</kwd><kwd>digital care</kwd><kwd>digital technology</kwd><kwd>young adult</kwd><kwd>teenager</kwd><kwd>juvenile</kwd><kwd>proof-of-concept</kwd><kwd>self monitor</kwd><kwd>EMA</kwd><kwd>overdose</kwd><kwd>formative research</kwd><kwd>counselor</kwd><kwd>qualitative interview</kwd></kwd-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><sec id="s1-1"><title>Background</title><p>Young adults, aged 18&#x2010;29 years, have the highest opioid use rate per capita [<xref ref-type="bibr" rid="ref1">1</xref>]. Despite the efficacy of medications (eg, methadone and buprenorphine) to prevent morbidity and mortality related to opioid use, young adults with opioid use disorder (OUD) are less likely to initiate treatment [<xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref3">3</xref>] and more likely to drop out of treatment [<xref ref-type="bibr" rid="ref4">4</xref>] compared to older age groups. A personalized behavioral treatment responsive to the individual needs of young adults may increase retention by addressing coping skills associated with young adults with OUD stressors and thoughts of leaving treatment [<xref ref-type="bibr" rid="ref5">5</xref>-<xref ref-type="bibr" rid="ref8">8</xref>].</p></sec><sec id="s1-2"><title>Addressing Risk Factors Through Ecological Momentary Assessment</title><p>The scientific understanding of risk assessment in a real-world context has been advanced by ecological momentary assessment (EMA) research methods [<xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref10">10</xref>]. EMA is a data collection technique requiring frequent self-monitoring of symptoms, thoughts, and social interactions, enabling the identification of unfolding patterns of mental states and behavior [<xref ref-type="bibr" rid="ref11">11</xref>]. Self-monitoring through text messaging (an EMA method) has been used extensively among people with OUD to identify treatment drop-out risk factors through pattern recognition [<xref ref-type="bibr" rid="ref12">12</xref>-<xref ref-type="bibr" rid="ref17">17</xref>].</p><p>People with OUD have differing retention trajectories based on levels of stress [<xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref>]. The variability of stress, not the averages at points in time, best predicts craving and future opioid use [<xref ref-type="bibr" rid="ref20">20</xref>]. According to self-management and cognitive relapse prevention theories, greater attention to and awareness of mental states may lead to improvements [<xref ref-type="bibr" rid="ref21">21</xref>,<xref ref-type="bibr" rid="ref22">22</xref>]. Drop-out risk factors like stress may normally be unconscious to a person, but self-monitoring can bring them to the forefront and, thus, increase the opportunity for the patient and counselor to develop more specific plans, coping strategies, and more control [<xref ref-type="bibr" rid="ref23">23</xref>]. It is likely that automatic responses to stress, when brought to cognitive awareness, become easier to address and extinguish [<xref ref-type="bibr" rid="ref24">24</xref>].</p><p>Previous research has incorporated EMA data within OUD treatment to engage participants through text messages to remind participants of appointments [<xref ref-type="bibr" rid="ref25">25</xref>], mobile health (mHealth) applications to deliver therapy [<xref ref-type="bibr" rid="ref26">26</xref>-<xref ref-type="bibr" rid="ref28">28</xref>], and web-based software to access and deliver cognitive behavioral therapy (CBT) [<xref ref-type="bibr" rid="ref29">29</xref>]. However, few digital interventions are described in the literature that incorporate EMA data into counseling sessions within an existing opioid treatment program (OTP). Integrating real-time patient-generated data at the point of care has the potential for a significant impact by informing risk assessment and augmenting existing treatment.</p></sec><sec id="s1-3"><title>Study Purpose</title><p>The present study developed and pilot-tested an intervention tailored for young adults with OUD called Awareness and Response to the Environment (AWARE). AWARE used Research Electronic Data Capture (REDCap; Vanderbilt University) software to send EMA surveys on a study-provided phone, collecting patient-generated data on antecedents of treatment drop-out that could be integrated into weekly counseling sessions. The purpose of this paper is to (1) describe the use of AWARE by young adults with OUD and treatment staff, (2) detail the perceived barriers and facilitators of treatment engagement, and (3) describe how AWARE may address identified barriers. This pilot, proof-of-concept project will lay the foundation for a future clinical trial of AWARE.</p></sec><sec id="s1-4"><title>Theoretical Framework</title><p>The conceptual framework for AWARE draws from self-management and cognitive-behavioral relapse prevention theories, which are applied to the retention stage of the OUD Cascade of Care [<xref ref-type="bibr" rid="ref30">30</xref>]. To target improvements in the retention stage, self-efficacy beliefs (&#x201C;I&#x2019;m going to the clinic today&#x201D;) and adherence (&#x201C;I received medication today&#x201D;) to medication are crucial [<xref ref-type="bibr" rid="ref31">31</xref>,<xref ref-type="bibr" rid="ref32">32</xref>]. Interventions underpinned by self-management theory in HIV and substance use research have shown success in increasing medication receipt and adherence [<xref ref-type="bibr" rid="ref33">33</xref>,<xref ref-type="bibr" rid="ref34">34</xref>]. Self-management theory emphasizes that improvements in self-efficacy beliefs can result in better decision-making and intention to adhere to healthy behaviors [<xref ref-type="bibr" rid="ref33">33</xref>-<xref ref-type="bibr" rid="ref35">35</xref>]. Cognitive-behavioral relapse prevention theory demonstrates that relapse (defined as a setback in progressing toward recovery) is not a binary event but, rather, a dynamic, fluctuating process (see <xref ref-type="fig" rid="figure1">Figure 1</xref>) [<xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref26">26</xref>]. The rationale for integrating these 2 theories stems from the utility of self-management&#x2013;based interventions in chronic disease and the chronic, relapsing nature of addiction [<xref ref-type="bibr" rid="ref34">34</xref>,<xref ref-type="bibr" rid="ref36">36</xref>]. Improved self-management skills for someone with OUD may prevent future relapses but also could improve daily cravings, negative mood, and stress, which may reflect a greater benefit to an individual than abstinence from drugs alone [<xref ref-type="bibr" rid="ref37">37</xref>]. These personal benefits may also positively reinforce treatment adherence, thereby making the work of recovery more appealing to participants [<xref ref-type="bibr" rid="ref38">38</xref>].</p><fig position="float" id="figure1"><label>Figure 1.</label><caption><p>Integration of AWARE components with theoretical frameworks. AWARE: Awareness and Response to the Environment; EMA: ecological momentary assessment.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="formative_v9i1e67401_fig01.png"/></fig></sec></sec><sec id="s2" sec-type="methods"><title>Methods</title><sec id="s2-1"><title>Setting and Design</title><p>Young adults with OUD and treatment staff recruitment took place at an urban, Northeastern United States OTP that offers methadone or buprenorphine and individual and group counseling informed by CBT, using the National Institute on Drug Abuse (NIDA) CBT manual [<xref ref-type="bibr" rid="ref39">39</xref>]. Each incoming patient receives an individual counselor with a caseload of 25&#x2010;30 patients. The OTP treated 426 patients in 2023 for OUD with either methadone (93%) or buprenorphine (7%). Approximately 10% of the patient population were young adults in 2023. The program does not currently use patient-centered digital health care technology. Medications administered and dispensed, as well as doses and drug screening results, are recorded in an electronic health record (EHR). Urine samples are obtained randomly at least twice per month, and patients are not discharged for drug use alone. Rather, continued opioid or other drug use may impact clinical decisions regarding take-home medication, dosage, and counseling approaches. Reasons for discharge are noted in the EHR. During our pilot study, we capitalized on already existing resources, including existing counselors, to adapt AWARE into the opioid treatment center structure. This study used a qualitative approach, which is appropriate for formative work. This article adheres to the COREQ (Consolidated Criteria for Reporting Qualitative Research) regarding key data collection and analysis aspects.</p></sec><sec id="s2-2"><title>AWARE Intervention</title><p>AWARE was developed as a self-monitoring, mobile phone&#x2013;based intervention that couples EMA surveys with counselor feedback during weekly CBT sessions. The goal of AWARE is to augment standard care, which includes medication, through identifying and responding to high-risk events or situations known to predict drop-out. The EMA structure, content, and timing in this project are informed by longitudinal studies that sought to predict early treatment dropout using EMA [<xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref40">40</xref>-<xref ref-type="bibr" rid="ref46">46</xref>]. For this pilot study, the Daily Hassles Survey [<xref ref-type="bibr" rid="ref18">18</xref>], a list of external stressors, was used to identify stressors particular to young adults with OUD. Weekly data summaries were provided to the participant and their counselor via email (see <xref ref-type="table" rid="table1">Table 1</xref>).</p><table-wrap id="t1" position="float"><label>Table 1.</label><caption><p>Awareness and Response to the Environment intervention integration of EMA data into counseling sessions for young adults with opioid use disorder.</p></caption><table id="table1" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Participation and roles of participant and counselor</td><td align="left" valign="bottom">Activities</td><td align="left" valign="bottom">Theoretical construct</td></tr></thead><tbody><tr><td align="left" valign="top">Participant (daily) self-monitors via EMA,<break/>views dashboard,<break/>real-world practice of skills</td><td align="left" valign="top">Identifies and examines thoughts, symptoms, triggers of drop-out; practices coping skills; practices problem solving</td><td align="left" valign="top">Self-efficacy, self-regulation, patient activation; coping, relapse or drop-out prevention; self-efficacy, relapse prevention;</td></tr><tr><td align="left" valign="top">Study counselor (weekly) views dashboard, analyzes patterns</td><td align="left" valign="top">Identifies and examines thoughts, symptoms, triggers of drop-out; identifies contextual issues affecting intention to stay in treatment; teaches and leads rehearsal of coping skills (emotional and trigger coping); engages in problem solving</td><td align="left" valign="top">Self-efficacy, self-regulation; self-efficacy, self-regulation; coping, relapse or drop-out prevention; coping, relapse, or drop-out prevention</td></tr></tbody></table></table-wrap></sec><sec id="s2-3"><title>Eligibility Criteria</title><p>The study recruited young adults with OUD who were (1) aged 18&#x2010;29 years, (2) receiving counseling during OUD treatment, and (3) English speaking. We excluded young adults with OUD if they exhibited (1) active suicidal ideation and/or (2) active psychosis. Inclusion criteria for treatment provider/staff interviews included (1) counselors with a client enrolled in AWARE or (2) clinic leadership.</p></sec><sec id="s2-4"><title>Recruitment and Screening Procedures</title><p>The research assistant approached eligible young adults with OUD participants during dosing, asking them if they would like to participate in a study regarding a mobile phone&#x2013;based intervention. The research assistant then obtained written informed consent and conducted the baseline interview. Participants were then oriented to the EMA survey procedures. Treatment center staff were recruited at a kick-off breakfast event at the treatment center. Staff provided verbal consent to the interviews before their interview began. Of the 14 young adult clients enrolled in the opioid treatment program, 8 were contacted and the research team never received a response; 3 were discharged from the treatment center before contact could be made, and 3 were successfully enrolled.</p></sec><sec id="s2-5"><title>Measures</title><p>All study participants completed a brief demographic questionnaire at baseline. In addition, young adults with OUD participants completed the daily stressors questionnaire. Qualitative interviews were performed using a semistructured guide before and after AWARE implementation. All participants were asked key questions regarding perceived barriers to treatment for young adults with OUD and the utility of AWARE in improving treatment engagement. Suggestions for improvement, as well as content or delivery methods, were obtained. Participants received a US$50 gift card upon completion of the qualitative interview. Young adults with OUD participants were paid US$50 in cash at the beginning and end of the AWARE intervention, and they also received a study phone if desired.</p></sec><sec id="s2-6"><title>Data Analysis</title><p>Interview data were analyzed using thematic analysis methods: generating initial codes, searching, reviewing, defining, and naming subthemes, and identifying basic and global themes. The research team consisted of a master&#x2019;s level Research Assistant and a PhD-prepared nurse scientist, each with extensive research and clinical experience working with young adults with OUD. Transcripts were reviewed independently by a master&#x2019;s prepared research assistant and a PhD-prepared investigator using rigorous and accelerated qualitative data reduction (RADaR) and content analysis [<xref ref-type="bibr" rid="ref47">47</xref>]. A series of spreadsheets was created to produce short, concise data tables. From the discussion of these tables, a consensus was reached on the content and relevance of themes identified. The identified daily stressors were tabulated using frequency of identification and ranked from most identified to least identified.</p></sec><sec id="s2-7"><title>Ethical Considerations</title><p>The study was approved by both WCG Institutional Review Board and the City of Philadelphia Department of Public Health Institutional Review Board (IRB# 2024-07). We obtained written, informed consent from all patient participants and verbal consent from the counselor and clinic leadership to be interviewed. All study data were deidentified before analysis. Participants were assigned unique study IDs, and no identifying information (eg, names, addresses, and phone numbers) was stored with survey or interview responses. Data collected through electronic platforms (eg, REDCap) were stored on secure, password-protected cloud-based storage systems compliant with institutional and Health Insurance Portability and Accountability Act (HIPAA) standards. Access to identifiable data was restricted to key research personnel and monitored through audit logs. All qualitative interview recordings were transcribed with identifying details removed and securely deleted after transcription. Findings are reported in aggregate form to ensure individual confidentiality. Patient and staff participants were paid US$50 for completing baseline and follow-up interviews at the beginning and end of the 4-week intervention period.</p></sec></sec><sec id="s3" sec-type="results"><title>Results</title><sec id="s3-1"><title>Overview</title><p>The 3 consented young adult participants with OUD (n=2, 67% female; n=2, 67% Latino/a) were sent daily surveys for 28 days (53% overall completion rate), and only 2 young adult participants with OUD finished the study. All 3 counselors received a weekly data summary. Young adults with OUD and counselor ratings of the usability of the platform were favorable; all agreed with statements that the daily surveys were clinically useful, easy to navigate, and relevant to the treatment experience. The young adults with OUD and treatment center staff interviews centered on the previously identified themes of treatment engagement stressors and barriers and the feasibility and usability of AWARE to promote treatment engagement.</p></sec><sec id="s3-2"><title>Participant Characteristics</title><p>Three young adult participants with OUD consented to participate in the study. The first participant was a Latina woman, aged 27 years, living in her own home with her partner and child. The second participant was a Latino man living in a family member&#x2019;s house. The third participant was a Black woman experiencing ongoing homelessness; however, she was lost to follow-up after responding to one week of surveys. All participants received a study phone to complete the AWARE surveys.</p><p>Five treatment center staff were recruited. All but one of the counselors had less than 6 years of experience as a drug and alcohol counselor. One clinic administrator had over 20 years of experience working in therapy within opioid treatment programs. Two treatment center staff identified as Black, one identified as Asian, and 2 identified as White. Treatment center staff interviewed primarily identified as women, except for one man.</p></sec><sec id="s3-3"><title>Treatment Engagement Stressors and Barriers for Young Adults</title><p>Over the 28-day period, young adults with OUD most frequently reported stressors related to family-related obligations (10 responses), having to do things without help (9 responses), and being organized (9 responses). Other common stressors included the health of a family member, physical care, and medical abilities (each 8 responses). In contrast, children, partners, and boredom (&#x201C;having enough to do&#x201D;) were reported least often (0&#x2013;3 responses). Overall, stressors spanned family, financial, health, and daily-life domains, with practical and relational demands emerging as the most prominent. In qualitative interviews, 2 young adults with OUD participants identified &#x201C;not having much to do&#x201D; and not having any social connections outside of the clinic as a frequent stressor. The most frequently reported daily stressors were identified as &#x201C;the health and well-being of a family member,&#x201D; &#x201C;being organized,&#x201D; and &#x201C;having too many things to do without help.&#x201D;</p><p>One participant described the care she provides daily for her child and her partner, who works night shift and is also a patient at the methadone clinic.</p><disp-quote><p>I have to be up and ready by 7:30 AM. [My partner is] outside and then I know we&#x2019;re coming to the clinic and he&#x2019;s tired, so he has to go home and sleep till he goes to work. So it&#x2019;s like I know I can&#x2019;t do nothing Monday through Friday but cater to him and the baby.</p><attrib>Participant 1</attrib></disp-quote><p>Each young adult with OUD reported in their interviews that they had difficulty in the past with clinic regulations and the clinic environment. This was not the first treatment episode for any young adults with OUD participants. The social environment around the clinic was not seen as positive. Most participants reported going to and from the clinic and not spending time with peers.</p><disp-quote><p>Well, it&#x2019;s like with this time, this isn&#x2019;t my first rodeo, so I know what to do this time. So I know this might not be the best answer, but this works for me. I isolate and it&#x2019;s not good. I isolate because I don&#x2019;t live in a nice neighborhood. There&#x2019;s drugs everywhere, but I don&#x2019;t like, it&#x2019;s definitely my mindset. I just go straight home and I try to keep a one track mind, but I mean, that wasn&#x2019;t good for me to do it back then.</p><attrib>Participant 3</attrib></disp-quote><p>Young adults with OUD participants also reported that they did not have much to do and making money at a job posed a problem, as they feared they might use the money for drugs.</p><disp-quote><p>Because you got to understand the last 10 years of my life getting high was my hobby, my interest. So when I just stop, you do feel lost, then that&#x2019;s when depression and being miserable, that all kicks in. You just don&#x2019;t know what to do. But I just got to find new shit to do, to keep me occupied, and I don&#x2019;t even know what to do right now. You know what I mean? It&#x2019;s weird. I feel like I&#x2019;m learning myself. I feel like how I felt when I was in high school. I am learning, trying to find myself, [trying to find things] that interest me instead of getting high.</p><attrib>Participant 3</attrib></disp-quote><p>Treatment center staff had a similar perspective to young adults with OUD regarding stressors and barriers to treatment engagement. All 5 treatment staff participants mentioned housing as a distinct barrier to stay in treatment. However, treatment center staff also highlighted issues related to childhood trauma, motivation, and family disconnection as barriers to maintaining recovery.</p><disp-quote><p>A lot of [clients] are not close with their families anymore, so I mean they don&#x2019;t have anything to look forward to. Holidays, everything is just a regular day to them, so because they don&#x2019;t have the motivation or the push, it makes it very difficult to keep them engaged on sobriety. They don&#x2019;t see a reason to be sober.</p><attrib>Staff 2</attrib></disp-quote><p>Difficulties staying away from drug use were linked by several treatment center staff to the environment in which participants lived and socialized. According to treatment center staff, there was little motivation to stay away from drugs and staying in treatment was lacking for many participants, due to a lack of positive relationships. Treatment staff also mentioned that the relationships that they do have at the treatment center are not always positive and that many times staying away from people is a strategy young adults employ in order to stay engaged in treatment.</p></sec><sec id="s3-4"><title>AWARE Feasibility, Acceptability, and Usability</title><p>Young adults and treatment center staff found AWARE to be relevant, acceptable, and feasible to complete over 4 weeks, although completion rates varied. Of the 3 young adults with OUD participants who began the AWARE intervention, only 2 completed over 90% of the 28 surveys sent. The third participant completed less than half of the surveys sent. Participants reported that it took 5&#x2010;10 minutes to complete their daily survey and that AWARE was &#x201C;easy to use&#x201D; and &#x201C;didn&#x2019;t take much time.&#x201D;</p><disp-quote><p>I think it pretty much everything made sense the way [AWARE] was set up because there wasn&#x2019;t too little questions or too much. It was kind of perfect to just reflect or more or less.</p><attrib>Participant 1</attrib></disp-quote><p>Young adults with OUD participants felt that AWARE was offering a type of social support, like &#x201C;someone checking in on them.&#x201D; One participant mentioned they were able to keep in contact with their parole officer as a result of having a study phone.</p><p>Clinic leadership and counselors reported that they felt AWARE presented a relevant, new way to engage young adults on a daily basis, in addition to weekly meetings. They also mentioned that AWARE allowed for anonymous reflection on the part of their clients. Counselors also appreciated that AWARE enabled weekly discussion of stressors based on patient-generated, real-time data.</p><disp-quote><p>[You] sent me a summary of my client&#x2019;s information, and I thought that was really helpful. I can actually bring this up in session and see what exactly going on. Because usually in session, it&#x2019;s kind of hard to pull that out of him or it&#x2019;s the generic, &#x201C;how are you doing,&#x201D; &#x201C;how&#x2019;s your week been,&#x201D; and &#x201C;it&#x2019;s fine, fine.&#x201D;</p><attrib>Staff 4</attrib></disp-quote><p>Treatment center staff also identified AWARE as an intervention that provides check-ins with their clients, addressing the scarcity of relationships in their clients&#x2019; lives. AWARE extended the reach of a positive relationship at the treatment center through automated messaging and required response.</p><disp-quote><p>And I think it&#x2019;s great because it&#x2019;s daily, because in a way it gives them something to feel a part of. Like somebody cares, there&#x2019;s a regular check-in. A lot of them don&#x2019;t have anything, don&#x2019;t have anybody asking them anything. Don&#x2019;t have any conversations, nobody checking in.</p><attrib>Staff 2</attrib></disp-quote></sec></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><sec id="s4-1"><title>Principal Findings</title><p>This is the first study to develop a patient-centered digital health care technology specifically for young adults in OUD treatment to promote retention through client-counselor engagement with EMA data. This pilot study sought to explore the use of AWARE among young adults with OUD and counselors to address the barriers and facilitators to treatment engagement. We aimed to identify barriers to treatment engagement and assess the potential of AWARE to address these barriers through real-time, technology-based support. Although preliminary, our findings provide valuable insights that lay the groundwork for a future clinical trial designed to rigorously evaluate the effectiveness of AWARE in improving treatment engagement and outcomes for this hard-to-reach population.</p><p>Initial findings from this pilot project indicate that delivery of daily surveys to young adult participants and the delivery of weekly summaries to counselors regarding stressors is not only possible but relevant to all involved. Previous research has found that people with OUD want a more personalized approach to treatment [<xref ref-type="bibr" rid="ref48">48</xref>]. Methadone treatment delivery is largely unchanged since initial federal regulations and policies were established in 1972 [<xref ref-type="bibr" rid="ref49">49</xref>]. New delivery methods are needed to promote treatment retention among young adults who demonstrate the highest opioid use rate per capita and the highest treatment drop-out rates [<xref ref-type="bibr" rid="ref50">50</xref>-<xref ref-type="bibr" rid="ref52">52</xref>]. To engage in treatment, young adults and others need treatment to be personalized and relevant to their circumstances (grounded in real-world experiences) [<xref ref-type="bibr" rid="ref48">48</xref>]. Previous mHealth research for people with OUD has not specifically targeted young adults who are hard to reach and underrepresented in treatment [<xref ref-type="bibr" rid="ref53">53</xref>-<xref ref-type="bibr" rid="ref55">55</xref>]. Future research should focus on engaging out-of-treatment populations of young adults with new delivery innovations.</p><p>Young adult participants with OUD identified several stressors that may interfere with treatment engagement, including housing, transportation, drug use, and family obligations. Improved self-management in response to stress, craving, and negative mood is particularly crucial for young adults who are in a stage of exploration and identity formation and who often experience high levels of impulsivity in response to external and internal triggers [<xref ref-type="bibr" rid="ref56">56</xref>,<xref ref-type="bibr" rid="ref57">57</xref>]. Two young adults with OUD participants identified &#x201C;not having much to do&#x201D; and not having any social connections outside of the clinic as frequent stressors. Among individuals with OUD, loneliness has been recognized as a factor that drives substance use and increases cravings, and it is linked to significant triggers that can lead to relapse [<xref ref-type="bibr" rid="ref58">58</xref>]. AWARE was able to reach out to participants on a daily basis and make them feel supported and less alone. It is possible that more contacts with positive relationships, through an intervention like AWARE, could not only increase treatment engagement but also begin to address social isolation.</p><p>Interventions that integrate a response to patient-generated data within existing substance use disorder treatment are more effective than self-monitoring alone at improving treatment retention [<xref ref-type="bibr" rid="ref59">59</xref>].&#x202F;&#x202F;However, patient-generated data has not been integrated within a direct point-of-care system workflow to inform treatment response to address drop-out risk factors at an opioid treatment center. AWARE presents an opportunity to integrate real-time patient-generated data at the point of care, which has the potential for significant impact by informing risk assessment and increasing opportunities for patient engagement and shared decision-making regarding treatment options. Such an approach promises to increase early treatment retention and thereby improve the quality of care and reduce the risk of overdose death.</p></sec><sec id="s4-2"><title>Limitations</title><p>All participants received the intervention. Future studies will be trials of AWARE and will include control and intervention groups to test the effect of AWARE. The small sample size of this specific study tested the recruitment strategy and highlighted the small number of young adults in treatment for OUD at a large, urban opioid treatment center at one point in time. As a result, findings are likely influenced by selection bias, particularly toward young adults who were more motivated to engage in research. The results may not reflect the broader population of young adults in OUD treatment. In addition, due to the limited sample size, thematic saturation was not achieved in qualitative interviews; findings should be interpreted as preliminary and exploratory, intended to inform future refinement and testing of the intervention.</p></sec><sec id="s4-3"><title>Conclusion</title><p>Overall, young adults with OUD and treatment staff participants were able to engage in AWARE in a busy OTP environment, and participants found it valuable. By addressing common stressors and providing a sense of social connection, AWARE may help fill a gap in support between counseling sessions for a hard-to-reach and underrepresented population in methadone treatment. Further research is needed to refine the measures and methods of AWARE and evaluate its effectiveness.</p></sec></sec></body><back><ack><p>This work was supported by the Friends Research Institute Pilot Award. KA was supported by the National Institute of Drug Abuse (R01DA057608-01).</p><p>Informed written consent was obtained from all young adult participants in the study. Informed verbal consent was obtained from all treatment providers. The authors obtained permission to publish from the City of Philadelphia.</p></ack><notes><sec><title>Data Availability</title><p>The deidentified data sets generated and analyzed during this study are not publicly available due to privacy and confidentiality considerations but are available from the corresponding author on reasonable request.</p></sec></notes><fn-group><fn fn-type="con"><p>KA conceived and designed the study, developed the methodology, and conducted the formal analysis. MS carried out the investigation, including material preparation and data collection, and contributed to data curation. KA drafted the initial version of the manuscript, and all authors contributed to reviewing and editing subsequent drafts. KA provided overall supervision of the project. All authors read and approved the final manuscript.</p></fn><fn fn-type="conflict"><p>None declared.</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term id="abb1">AWARE</term><def><p>Awareness and Response to the Environment</p></def></def-item><def-item><term id="abb2">CBT</term><def><p>cognitive behavioral therapy</p></def></def-item><def-item><term id="abb3">COREQ</term><def><p>Consolidated Criteria for Reporting Qualitative Research</p></def></def-item><def-item><term id="abb4">EHR</term><def><p>electronic health record</p></def></def-item><def-item><term id="abb5">EMA</term><def><p>ecological momentary assessment</p></def></def-item><def-item><term id="abb6">HIPAA</term><def><p>Health Insurance Portability and Accountability Act</p></def></def-item><def-item><term id="abb7">mHealth</term><def><p>mobile health</p></def></def-item><def-item><term id="abb8">NIDA</term><def><p>National Institute on Drug Abuse</p></def></def-item><def-item><term id="abb9">OTP</term><def><p>opioid treatment program</p></def></def-item><def-item><term id="abb10">OUD</term><def><p>opioid use disorder</p></def></def-item><def-item><term id="abb11">RADaR</term><def><p>rigorous and accelerated data reduction</p></def></def-item><def-item><term id="abb12">REDCap</term><def><p>Research Electronic Data Capture</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><label>1</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>GK</given-names> </name><name name-style="western"><surname>Kim</surname><given-names>IE</given-names> </name><name name-style="western"><surname>Girmay</surname><given-names>M</given-names> </name><etal/></person-group><article-title>Opioid epidemic in the United States: empirical trends, and a literature review of social determinants and epidemiological, pain management, and treatment patterns</article-title><source>Int J MCH AIDS</source><year>2019</year><volume>8</volume><issue>2</issue><fpage>89</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.21106/ijma.284</pub-id><pub-id pub-id-type="medline">31723479</pub-id></nlm-citation></ref><ref id="ref2"><label>2</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choi</surname><given-names>S</given-names> </name><name name-style="western"><surname>Yerneni</surname><given-names>R</given-names> </name><name name-style="western"><surname>Healy</surname><given-names>S</given-names> </name><name name-style="western"><surname>Goyal</surname><given-names>M</given-names> </name><name name-style="western"><surname>Neighbors</surname><given-names>CJ</given-names> </name></person-group><article-title>Predictors of medication utilization for opioid use disorder among medicaid-insured HIV patients in New York</article-title><source>Am J Addict</source><year>2020</year><month>03</month><volume>29</volume><issue>2</issue><fpage>151</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1111/ajad.12998</pub-id><pub-id pub-id-type="medline">31951083</pub-id></nlm-citation></ref><ref id="ref3"><label>3</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hadland</surname><given-names>SE</given-names> </name><name name-style="western"><surname>Wharam</surname><given-names>JF</given-names> </name><name name-style="western"><surname>Schuster</surname><given-names>MA</given-names> </name><name name-style="western"><surname>Zhang</surname><given-names>F</given-names> </name><name name-style="western"><surname>Samet</surname><given-names>JH</given-names> </name><name name-style="western"><surname>Larochelle</surname><given-names>MR</given-names> </name></person-group><article-title>Trends in receipt of buprenorphine and naltrexone for opioid use disorder among adolescents and young adults, 2001-2014</article-title><source>JAMA Pediatr</source><year>2017</year><month>08</month><day>1</day><volume>171</volume><issue>8</issue><fpage>747</fpage><lpage>755</lpage><pub-id pub-id-type="doi">10.1001/jamapediatrics.2017.0745</pub-id><pub-id pub-id-type="medline">28628701</pub-id></nlm-citation></ref><ref id="ref4"><label>4</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alexander</surname><given-names>K</given-names> </name><name name-style="western"><surname>Reed</surname><given-names>MK</given-names> </name><name name-style="western"><surname>Sterling</surname><given-names>RC</given-names> </name></person-group><article-title>The interaction of race and age in methadone treatment retention outcomes: a single-center analysis</article-title><source>J Subst Use Addict Treat</source><year>2023</year><month>05</month><volume>148</volume><fpage>209020</fpage><pub-id pub-id-type="doi">10.1016/j.josat.2023.209020</pub-id><pub-id pub-id-type="medline">36933661</pub-id></nlm-citation></ref><ref id="ref5"><label>5</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dugosh</surname><given-names>K</given-names> </name><name name-style="western"><surname>Abraham</surname><given-names>A</given-names> </name><name name-style="western"><surname>Seymour</surname><given-names>B</given-names> </name><name name-style="western"><surname>McLoyd</surname><given-names>K</given-names> </name><name name-style="western"><surname>Chalk</surname><given-names>M</given-names> </name><name name-style="western"><surname>Festinger</surname><given-names>D</given-names> </name></person-group><article-title>A systematic review on the use of psychosocial interventions in conjunction with medications for the treatment of opioid addiction</article-title><source>J Addict Med</source><year>2016</year><volume>10</volume><issue>2</issue><fpage>93</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1097/ADM.0000000000000193</pub-id><pub-id pub-id-type="medline">26808307</pub-id></nlm-citation></ref><ref id="ref6"><label>6</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krawczyk</surname><given-names>N</given-names> </name><name name-style="western"><surname>Williams</surname><given-names>AR</given-names> </name><name name-style="western"><surname>Saloner</surname><given-names>B</given-names> </name><name name-style="western"><surname>Cerd&#x00E1;</surname><given-names>M</given-names> </name></person-group><article-title>Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings</article-title><source>J Subst Abuse Treat</source><year>2021</year><month>07</month><volume>126</volume><fpage>108329</fpage><pub-id pub-id-type="doi">10.1016/j.jsat.2021.108329</pub-id><pub-id pub-id-type="medline">34116820</pub-id></nlm-citation></ref><ref id="ref7"><label>7</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>LA</given-names> </name><name name-style="western"><surname>Lofwall</surname><given-names>MR</given-names> </name><name name-style="western"><surname>Walsh</surname><given-names>SL</given-names> </name><name name-style="western"><surname>Knudsen</surname><given-names>HK</given-names> </name></person-group><article-title>Perceived need and availability of psychosocial interventions across buprenorphine prescriber specialties</article-title><source>Addict Behav</source><year>2019</year><month>06</month><volume>93</volume><fpage>72</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.addbeh.2019.01.023</pub-id><pub-id pub-id-type="medline">30690416</pub-id></nlm-citation></ref><ref id="ref8"><label>8</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mart&#x00ED;nez-Vispo</surname><given-names>C</given-names> </name><name name-style="western"><surname>Mart&#x00ED;nez</surname><given-names>&#x00DA;</given-names> </name><name name-style="western"><surname>L&#x00F3;pez-Dur&#x00E1;n</surname><given-names>A</given-names> </name><name name-style="western"><surname>Fern&#x00E1;ndez Del R&#x00ED;o</surname><given-names>E</given-names> </name><name name-style="western"><surname>Beco&#x00F1;a</surname><given-names>E</given-names> </name></person-group><article-title>Effects of behavioural activation on substance use and depression: a systematic review</article-title><source>Subst Abuse Treat Prev Policy</source><year>2018</year><month>09</month><day>29</day><volume>13</volume><issue>1</issue><fpage>36</fpage><pub-id pub-id-type="doi">10.1186/s13011-018-0173-2</pub-id><pub-id pub-id-type="medline">30268136</pub-id></nlm-citation></ref><ref id="ref9"><label>9</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burgess-Hull</surname><given-names>A</given-names> </name><name name-style="western"><surname>Epstein</surname><given-names>DH</given-names> </name></person-group><article-title>Ambulatory assessment methods to examine momentary state-based predictors of opioid use behaviors</article-title><source>Curr Addict Rep</source><year>2021</year><volume>8</volume><issue>1</issue><fpage>122</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1007/s40429-020-00351-7</pub-id><pub-id pub-id-type="medline">33425652</pub-id></nlm-citation></ref><ref id="ref10"><label>10</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McDevitt-Murphy</surname><given-names>ME</given-names> </name><name name-style="western"><surname>Luciano</surname><given-names>MT</given-names> </name><name name-style="western"><surname>Zakarian</surname><given-names>RJ</given-names> </name></person-group><article-title>Use of ecological momentary assessment and intervention in treatment with adults</article-title><source>Focus (Am Psychiatr Publ)</source><year>2018</year><volume>16</volume><issue>4</issue><fpage>370</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1176/appi.focus.20180017</pub-id><pub-id pub-id-type="medline">31191181</pub-id></nlm-citation></ref><ref id="ref11"><label>11</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shiffman</surname><given-names>S</given-names> </name><name name-style="western"><surname>Stone</surname><given-names>AA</given-names> </name><name name-style="western"><surname>Hufford</surname><given-names>MR</given-names> </name></person-group><article-title>Ecological momentary assessment</article-title><source>Annu Rev Clin Psychol</source><year>2008</year><volume>4</volume><fpage>1</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1146/annurev.clinpsy.3.022806.091415</pub-id><pub-id pub-id-type="medline">18509902</pub-id></nlm-citation></ref><ref id="ref12"><label>12</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alexander</surname><given-names>K</given-names> </name><name name-style="western"><surname>Sanjuan</surname><given-names>P</given-names> </name><name name-style="western"><surname>Terplan</surname><given-names>M</given-names> </name></person-group><article-title>The use of ecological momentary assessment methods with people receiving medication for opioid use disorder: a systematic review</article-title><source>Curr Addict Rep</source><year>2023</year><volume>10</volume><issue>3</issue><fpage>366</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1007/s40429-023-00492-5</pub-id></nlm-citation></ref><ref id="ref13"><label>13</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miranda</surname><given-names>R</given-names> </name><name name-style="western"><surname>Treloar Padovano</surname><given-names>H</given-names> </name><name name-style="western"><surname>Gray</surname><given-names>JC</given-names> </name><name name-style="western"><surname>Wemm</surname><given-names>SE</given-names> </name><name name-style="western"><surname>Blanchard</surname><given-names>A</given-names> </name></person-group><article-title>Real-time assessment of alcohol craving and naltrexone treatment responsiveness in a randomized clinical trial</article-title><source>Addict Behav</source><year>2018</year><month>08</month><volume>83</volume><fpage>72</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/j.addbeh.2018.01.009</pub-id><pub-id pub-id-type="medline">29395188</pub-id></nlm-citation></ref><ref id="ref14"><label>14</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burgess-Hull</surname><given-names>AJ</given-names> </name><name name-style="western"><surname>Smith</surname><given-names>KE</given-names> </name><name name-style="western"><surname>Schriefer</surname><given-names>D</given-names> </name><name name-style="western"><surname>Panlilio</surname><given-names>LV</given-names> </name><name name-style="western"><surname>Epstein</surname><given-names>DH</given-names> </name><name name-style="western"><surname>Preston</surname><given-names>KL</given-names> </name></person-group><article-title>Longitudinal patterns of momentary stress during outpatient opioid agonist treatment: a growth-mixture-model approach to classifying patients</article-title><source>Drug Alcohol Depend</source><year>2021</year><month>09</month><day>1</day><volume>226</volume><fpage>108884</fpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2021.108884</pub-id><pub-id pub-id-type="medline">34229153</pub-id></nlm-citation></ref><ref id="ref15"><label>15</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chandra</surname><given-names>S</given-names> </name><name name-style="western"><surname>Scharf</surname><given-names>D</given-names> </name><name name-style="western"><surname>Shiffman</surname><given-names>S</given-names> </name></person-group><article-title>Within-day temporal patterns of smoking, withdrawal symptoms, and craving</article-title><source>Drug Alcohol Depend</source><year>2011</year><month>09</month><day>1</day><volume>117</volume><issue>2-3</issue><fpage>118</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2010.12.027</pub-id><pub-id pub-id-type="medline">21324611</pub-id></nlm-citation></ref><ref id="ref16"><label>16</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kennedy</surname><given-names>AP</given-names> </name><name name-style="western"><surname>Epstein</surname><given-names>DH</given-names> </name><name name-style="western"><surname>Phillips</surname><given-names>KA</given-names> </name><name name-style="western"><surname>Preston</surname><given-names>KL</given-names> </name></person-group><article-title>Sex differences in cocaine/heroin users: drug-use triggers and craving in daily life</article-title><source>Drug Alcohol Depend</source><year>2013</year><month>09</month><day>1</day><volume>132</volume><issue>1-2</issue><fpage>29</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2012.12.025</pub-id><pub-id pub-id-type="medline">23357742</pub-id></nlm-citation></ref><ref id="ref17"><label>17</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Panlilio</surname><given-names>LV</given-names> </name><name name-style="western"><surname>Stull</surname><given-names>SW</given-names> </name><name name-style="western"><surname>Bertz</surname><given-names>JW</given-names> </name><etal/></person-group><article-title>Beyond abstinence and relapse II: momentary relationships between stress, craving, and lapse within clusters of patients with similar patterns of drug use</article-title><source>Psychopharmacology (Berl)</source><year>2021</year><month>06</month><volume>238</volume><issue>6</issue><fpage>1513</fpage><lpage>1529</lpage><pub-id pub-id-type="doi">10.1007/s00213-021-05782-2</pub-id><pub-id pub-id-type="medline">33558983</pub-id></nlm-citation></ref><ref id="ref18"><label>18</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Preston</surname><given-names>KL</given-names> </name><name name-style="western"><surname>Schroeder</surname><given-names>JR</given-names> </name><name name-style="western"><surname>Kowalczyk</surname><given-names>WJ</given-names> </name><etal/></person-group><article-title>End-of-day reports of daily hassles and stress in men and women with opioid-use disorder: relationship to momentary reports of opioid and cocaine use and stress</article-title><source>Drug Alcohol Depend</source><year>2018</year><month>12</month><day>1</day><volume>193</volume><fpage>21</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2018.08.023</pub-id><pub-id pub-id-type="medline">30336389</pub-id></nlm-citation></ref><ref id="ref19"><label>19</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moran</surname><given-names>LM</given-names> </name><name name-style="western"><surname>Kowalczyk</surname><given-names>WJ</given-names> </name><name name-style="western"><surname>Phillips</surname><given-names>KA</given-names> </name><etal/></person-group><article-title>Sex differences in daily life stress and craving in opioid-dependent patients</article-title><source>Am J Drug Alcohol Abuse</source><year>2018</year><volume>44</volume><issue>5</issue><fpage>512</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1080/00952990.2018.1454934</pub-id><pub-id pub-id-type="medline">29641291</pub-id></nlm-citation></ref><ref id="ref20"><label>20</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Panlilio</surname><given-names>LV</given-names> </name><name name-style="western"><surname>Stull</surname><given-names>SW</given-names> </name><name name-style="western"><surname>Kowalczyk</surname><given-names>WJ</given-names> </name><etal/></person-group><article-title>Stress, craving and mood as predictors of early dropout from opioid agonist therapy</article-title><source>Drug Alcohol Depend</source><year>2019</year><month>09</month><day>1</day><volume>202</volume><fpage>200</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2019.05.026</pub-id><pub-id pub-id-type="medline">31357121</pub-id></nlm-citation></ref><ref id="ref21"><label>21</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hendershot</surname><given-names>CS</given-names> </name><name name-style="western"><surname>Witkiewitz</surname><given-names>K</given-names> </name><name name-style="western"><surname>George</surname><given-names>WH</given-names> </name><name name-style="western"><surname>Marlatt</surname><given-names>GA</given-names> </name></person-group><article-title>Relapse prevention for addictive behaviors</article-title><source>Subst Abuse Treat Prev Policy</source><year>2011</year><month>07</month><day>19</day><volume>6</volume><fpage>17</fpage><pub-id pub-id-type="doi">10.1186/1747-597X-6-17</pub-id><pub-id pub-id-type="medline">21771314</pub-id></nlm-citation></ref><ref id="ref22"><label>22</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Larimer</surname><given-names>ME</given-names> </name><name name-style="western"><surname>Palmer</surname><given-names>RS</given-names> </name><name name-style="western"><surname>Marlatt</surname><given-names>GA</given-names> </name></person-group><article-title>Relapse prevention. An overview of Marlatt&#x2019;s cognitive-behavioral model</article-title><source>Alcohol Res Health</source><year>1999</year><volume>23</volume><issue>2</issue><fpage>151</fpage><lpage>160</lpage><pub-id pub-id-type="medline">10890810</pub-id></nlm-citation></ref><ref id="ref23"><label>23</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tiffany</surname><given-names>ST</given-names> </name></person-group><article-title>A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes</article-title><source>Psychol Rev</source><year>1990</year><month>04</month><volume>97</volume><issue>2</issue><fpage>147</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1037/0033-295x.97.2.147</pub-id><pub-id pub-id-type="medline">2186423</pub-id></nlm-citation></ref><ref id="ref24"><label>24</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karoly</surname><given-names>P</given-names> </name></person-group><article-title>Mechanisms of self-regulation: a systems view</article-title><source>Annu Rev Psychol</source><year>1993</year><month>01</month><volume>44</volume><issue>1</issue><fpage>23</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1146/annurev.ps.44.020193.000323</pub-id></nlm-citation></ref><ref id="ref25"><label>25</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tofighi</surname><given-names>B</given-names> </name><name name-style="western"><surname>Badiei</surname><given-names>B</given-names> </name><name name-style="western"><surname>Badolato</surname><given-names>R</given-names> </name><etal/></person-group><article-title>Integrating text messaging in a low threshold telebuprenorphine program for New York City residents with opioid use disorder during COVID-19: a pilot randomized controlled trial</article-title><source>J Addict Med</source><year>2023</year><volume>17</volume><issue>5</issue><fpage>e281</fpage><lpage>e286</lpage><pub-id pub-id-type="doi">10.1097/ADM.0000000000001161</pub-id><pub-id pub-id-type="medline">37788603</pub-id></nlm-citation></ref><ref id="ref26"><label>26</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Monico</surname><given-names>LB</given-names> </name><name name-style="western"><surname>Eastlick</surname><given-names>M</given-names> </name><name name-style="western"><surname>Michero</surname><given-names>D</given-names> </name><name name-style="western"><surname>Pielsticker</surname><given-names>P</given-names> </name><name name-style="western"><surname>Glasner</surname><given-names>S</given-names> </name></person-group><article-title>Feasibility and acceptability of a novel digital therapeutic combining behavioral and pharmacological treatment for opioid use disorder</article-title><source>Digit Health</source><year>2024</year><volume>10</volume><fpage>20552076241258400</fpage><pub-id pub-id-type="doi">10.1177/20552076241258400</pub-id><pub-id pub-id-type="medline">38812851</pub-id></nlm-citation></ref><ref id="ref27"><label>27</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marsch</surname><given-names>LA</given-names> </name><name name-style="western"><surname>Guarino</surname><given-names>H</given-names> </name><name name-style="western"><surname>Acosta</surname><given-names>M</given-names> </name><etal/></person-group><article-title>Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment</article-title><source>J Subst Abuse Treat</source><year>2014</year><month>01</month><volume>46</volume><issue>1</issue><fpage>43</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.jsat.2013.08.012</pub-id><pub-id pub-id-type="medline">24060350</pub-id></nlm-citation></ref><ref id="ref28"><label>28</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ashrafioun</surname><given-names>L</given-names> </name><name name-style="western"><surname>Allan</surname><given-names>NP</given-names> </name><name name-style="western"><surname>Stecker</surname><given-names>TA</given-names> </name></person-group><article-title>A randomized clinical trial to assess feasibility, acceptability and preliminary effects of telehealth-delivered cognitive-behavioral therapy for perceived social isolation among individuals with opioid use disorders</article-title><source>Drug Alcohol Depend</source><year>2024</year><month>05</month><day>1</day><volume>258</volume><fpage>111268</fpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2024.111268</pub-id><pub-id pub-id-type="medline">38520791</pub-id></nlm-citation></ref><ref id="ref29"><label>29</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carroll</surname><given-names>KM</given-names> </name><name name-style="western"><surname>Kiluk</surname><given-names>BD</given-names> </name><name name-style="western"><surname>Nich</surname><given-names>C</given-names> </name><etal/></person-group><article-title>Computer-assisted delivery of cognitive-behavioral therapy: efficacy and durability of CBT4CBT among cocaine-dependent individuals maintained on methadone</article-title><source>Am J Psychiatry</source><year>2014</year><month>04</month><volume>171</volume><issue>4</issue><fpage>436</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.2013.13070987</pub-id><pub-id pub-id-type="medline">24577287</pub-id></nlm-citation></ref><ref id="ref30"><label>30</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>AR</given-names> </name><name name-style="western"><surname>Nunes</surname><given-names>EV</given-names> </name><name name-style="western"><surname>Bisaga</surname><given-names>A</given-names> </name><etal/></person-group><article-title>Developing an opioid use disorder treatment cascade: a review of quality measures</article-title><source>J Subst Abuse Treat</source><year>2018</year><month>08</month><volume>91</volume><fpage>57</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/j.jsat.2018.06.001</pub-id><pub-id pub-id-type="medline">29910015</pub-id></nlm-citation></ref><ref id="ref31"><label>31</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sheeran</surname><given-names>P</given-names> </name><name name-style="western"><surname>Maki</surname><given-names>A</given-names> </name><name name-style="western"><surname>Montanaro</surname><given-names>E</given-names> </name><etal/></person-group><article-title>The impact of changing attitudes, norms, and self-efficacy on health-related intentions and behavior: a meta-analysis</article-title><source>Health Psychol</source><year>2016</year><month>11</month><volume>35</volume><issue>11</issue><fpage>1178</fpage><lpage>1188</lpage><pub-id pub-id-type="doi">10.1037/hea0000387</pub-id><pub-id pub-id-type="medline">27280365</pub-id></nlm-citation></ref><ref id="ref32"><label>32</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barta</surname><given-names>WD</given-names> </name><name name-style="western"><surname>Kurth</surname><given-names>ME</given-names> </name><name name-style="western"><surname>Stein</surname><given-names>MD</given-names> </name><name name-style="western"><surname>Tennen</surname><given-names>H</given-names> </name><name name-style="western"><surname>Kiene</surname><given-names>SM</given-names> </name></person-group><article-title>Craving and self-efficacy in the first five weeks of methadone maintenance therapy: a daily process study</article-title><source>J Stud Alcohol Drugs</source><year>2009</year><month>09</month><volume>70</volume><issue>5</issue><fpage>735</fpage><lpage>740</lpage><pub-id pub-id-type="doi">10.15288/jsad.2009.70.735</pub-id><pub-id pub-id-type="medline">19737498</pub-id></nlm-citation></ref><ref id="ref33"><label>33</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gass</surname><given-names>JC</given-names> </name><name name-style="western"><surname>Funderburk</surname><given-names>JS</given-names> </name><name name-style="western"><surname>Shepardson</surname><given-names>R</given-names> </name><name name-style="western"><surname>Kosiba</surname><given-names>JD</given-names> </name><name name-style="western"><surname>Rodriguez</surname><given-names>L</given-names> </name><name name-style="western"><surname>Maisto</surname><given-names>SA</given-names> </name></person-group><article-title>The use and impact of self-monitoring on substance use outcomes: a descriptive systematic review</article-title><source>Subst Abus</source><year>2021</year><volume>42</volume><issue>4</issue><fpage>512</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1080/08897077.2021.1874595</pub-id><pub-id pub-id-type="medline">33617740</pub-id></nlm-citation></ref><ref id="ref34"><label>34</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Swendeman</surname><given-names>D</given-names> </name><name name-style="western"><surname>Ramanathan</surname><given-names>N</given-names> </name><name name-style="western"><surname>Baetscher</surname><given-names>L</given-names> </name><etal/></person-group><article-title>Smartphone self-monitoring to support self-management among people living with HIV: perceived benefits and theory of change from a mixed-methods randomized pilot study</article-title><source>J Acquir Immune Defic Syndr</source><year>2015</year><month>05</month><day>1</day><volume>69 Suppl 1</volume><issue>1</issue><fpage>S80</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1097/QAI.0000000000000570</pub-id><pub-id pub-id-type="medline">25867783</pub-id></nlm-citation></ref><ref id="ref35"><label>35</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Svendsen</surname><given-names>TS</given-names> </name><name name-style="western"><surname>Bjornestad</surname><given-names>J</given-names> </name><name name-style="western"><surname>Slyngstad</surname><given-names>TE</given-names> </name><etal/></person-group><article-title>&#x201C;Becoming myself&#x201D;: how participants in a longitudinal substance use disorder recovery study experienced receiving continuous feedback on their results</article-title><source>Subst Abuse Treat Prev Policy</source><year>2020</year><month>01</month><day>23</day><volume>15</volume><issue>1</issue><fpage>8</fpage><pub-id pub-id-type="doi">10.1186/s13011-020-0254-x</pub-id><pub-id pub-id-type="medline">31973763</pub-id></nlm-citation></ref><ref id="ref36"><label>36</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dunbar-Jacob</surname><given-names>J</given-names> </name><name name-style="western"><surname>Mortimer-Stephens</surname><given-names>MK</given-names> </name></person-group><article-title>Treatment adherence in chronic disease</article-title><source>J Clin Epidemiol</source><year>2001</year><month>12</month><volume>54 Suppl 1</volume><fpage>S57</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/s0895-4356(01)00457-7</pub-id><pub-id pub-id-type="medline">11750211</pub-id></nlm-citation></ref><ref id="ref37"><label>37</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carver</surname><given-names>CS</given-names> </name><name name-style="western"><surname>Scheier</surname><given-names>MF</given-names> </name><name name-style="western"><surname>Weintraub</surname><given-names>JK</given-names> </name></person-group><article-title>Assessing coping strategies: a theoretically based approach</article-title><source>J Pers Soc Psychol</source><year>1989</year><volume>56</volume><issue>2</issue><fpage>267</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1037/0022-3514.56.2.267</pub-id><pub-id pub-id-type="medline">2926629</pub-id></nlm-citation></ref><ref id="ref38"><label>38</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McKay</surname><given-names>JR</given-names> </name></person-group><article-title>Making the hard work of recovery more attractive for those with substance use disorders</article-title><source>Addiction</source><year>2017</year><month>05</month><volume>112</volume><issue>5</issue><fpage>751</fpage><lpage>757</lpage><pub-id pub-id-type="doi">10.1111/add.13502</pub-id><pub-id pub-id-type="medline">27535787</pub-id></nlm-citation></ref><ref id="ref39"><label>39</label><nlm-citation citation-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Carroll</surname><given-names>KM</given-names> </name></person-group><source>Therapy Manuals for Drug Addiction, Manual 1: A Cognitive-Behavioral Approach: Treating Cocaine Addiction</source><year>1998</year><publisher-name>National Institute on Drug Abuse</publisher-name><fpage>55</fpage><lpage>65</lpage></nlm-citation></ref><ref id="ref40"><label>40</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Preston</surname><given-names>KL</given-names> </name><name name-style="western"><surname>Kowalczyk</surname><given-names>WJ</given-names> </name><name name-style="western"><surname>Phillips</surname><given-names>KA</given-names> </name><etal/></person-group><article-title>Before and after: craving, mood, and background stress in the hours surrounding drug use and stressful events in patients with opioid-use disorder</article-title><source>Psychopharmacology (Berl)</source><year>2018</year><month>09</month><volume>235</volume><issue>9</issue><fpage>2713</fpage><lpage>2723</lpage><pub-id pub-id-type="doi">10.1007/s00213-018-4966-9</pub-id><pub-id pub-id-type="medline">29980821</pub-id></nlm-citation></ref><ref id="ref41"><label>41</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Preston</surname><given-names>KL</given-names> </name><name name-style="western"><surname>Kowalczyk</surname><given-names>WJ</given-names> </name><name name-style="western"><surname>Phillips</surname><given-names>KA</given-names> </name><etal/></person-group><article-title>Context and craving during stressful events in the daily lives of drug-dependent patients</article-title><source>Psychopharmacology (Berl)</source><year>2017</year><month>09</month><volume>234</volume><issue>17</issue><fpage>2631</fpage><lpage>2642</lpage><pub-id pub-id-type="doi">10.1007/s00213-017-4663-0</pub-id><pub-id pub-id-type="medline">28593441</pub-id></nlm-citation></ref><ref id="ref42"><label>42</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Preston</surname><given-names>KL</given-names> </name><name name-style="western"><surname>Epstein</surname><given-names>DH</given-names> </name></person-group><article-title>Stress in the daily lives of cocaine and heroin users: relationship to mood, craving, relapse triggers, and cocaine use</article-title><source>Psychopharmacology (Berl)</source><year>2011</year><month>11</month><volume>218</volume><issue>1</issue><fpage>29</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1007/s00213-011-2183-x</pub-id><pub-id pub-id-type="medline">21336579</pub-id></nlm-citation></ref><ref id="ref43"><label>43</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kowalczyk</surname><given-names>WJ</given-names> </name><name name-style="western"><surname>Moran</surname><given-names>LM</given-names> </name><name name-style="western"><surname>Bertz</surname><given-names>JW</given-names> </name><etal/></person-group><article-title>Using ecological momentary assessment to examine the relationship between craving and affect with opioid use in a clinical trial of clonidine as an adjunct medication to buprenorphine treatment</article-title><source>Am J Drug Alcohol Abuse</source><year>2018</year><volume>44</volume><issue>5</issue><fpage>502</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1080/00952990.2018.1454933</pub-id><pub-id pub-id-type="medline">29634425</pub-id></nlm-citation></ref><ref id="ref44"><label>44</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moran</surname><given-names>LM</given-names> </name><name name-style="western"><surname>Phillips</surname><given-names>KA</given-names> </name><name name-style="western"><surname>Kowalczyk</surname><given-names>WJ</given-names> </name><etal/></person-group><article-title>Aripiprazole for cocaine abstinence: a randomized-controlled trial with ecological momentary assessment</article-title><source>Behav Pharmacol</source><year>2017</year><month>02</month><volume>28</volume><issue>1</issue><fpage>63</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1097/FBP.0000000000000268</pub-id><pub-id pub-id-type="medline">27755017</pub-id></nlm-citation></ref><ref id="ref45"><label>45</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Preston</surname><given-names>KL</given-names> </name><name name-style="western"><surname>Vahabzadeh</surname><given-names>M</given-names> </name><name name-style="western"><surname>Schmittner</surname><given-names>J</given-names> </name><name name-style="western"><surname>Lin</surname><given-names>JL</given-names> </name><name name-style="western"><surname>Gorelick</surname><given-names>DA</given-names> </name><name name-style="western"><surname>Epstein</surname><given-names>DH</given-names> </name></person-group><article-title>Cocaine craving and use during daily life</article-title><source>Psychopharmacology (Berl)</source><year>2009</year><month>12</month><volume>207</volume><issue>2</issue><fpage>291</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1007/s00213-009-1655-8</pub-id><pub-id pub-id-type="medline">19777216</pub-id></nlm-citation></ref><ref id="ref46"><label>46</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Preston</surname><given-names>KL</given-names> </name><name name-style="western"><surname>Jobes</surname><given-names>ML</given-names> </name><name name-style="western"><surname>Phillips</surname><given-names>KA</given-names> </name><name name-style="western"><surname>Epstein</surname><given-names>DH</given-names> </name></person-group><article-title>Real-time assessment of alcohol drinking and drug use in opioid-dependent polydrug users</article-title><source>Behav Pharmacol</source><year>2016</year><month>10</month><volume>27</volume><issue>7</issue><fpage>579</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1097/FBP.0000000000000250</pub-id><pub-id pub-id-type="medline">27579810</pub-id></nlm-citation></ref><ref id="ref47"><label>47</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Watkins</surname><given-names>DC</given-names> </name></person-group><article-title>Rapid and Rigorous Qualitative Data Analysis: The &#x201C;RADaR&#x201D; technique for applied research</article-title><source>Int J Qual Methods</source><year>2017</year><volume>16</volume><issue>1</issue><fpage>1609406917712131</fpage><pub-id pub-id-type="doi">10.1177/1609406917712131</pub-id></nlm-citation></ref><ref id="ref48"><label>48</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kourounis</surname><given-names>G</given-names> </name><name name-style="western"><surname>Richards</surname><given-names>BDW</given-names> </name><name name-style="western"><surname>Kyprianou</surname><given-names>E</given-names> </name><name name-style="western"><surname>Symeonidou</surname><given-names>E</given-names> </name><name name-style="western"><surname>Malliori</surname><given-names>MM</given-names> </name><name name-style="western"><surname>Samartzis</surname><given-names>L</given-names> </name></person-group><article-title>Opioid substitution therapy: lowering the treatment thresholds</article-title><source>Drug Alcohol Depend</source><year>2016</year><month>04</month><day>1</day><volume>161</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2015.12.021</pub-id><pub-id pub-id-type="medline">26832931</pub-id></nlm-citation></ref><ref id="ref49"><label>49</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schwartz</surname><given-names>RP</given-names> </name><name name-style="western"><surname>Kelly</surname><given-names>SM</given-names> </name><name name-style="western"><surname>Mitchell</surname><given-names>SG</given-names> </name><etal/></person-group><article-title>Patient-centered methadone treatment: a randomized clinical trial</article-title><source>Addiction</source><year>2017</year><month>03</month><volume>112</volume><issue>3</issue><fpage>454</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1111/add.13622</pub-id><pub-id pub-id-type="medline">27661788</pub-id></nlm-citation></ref><ref id="ref50"><label>50</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bagley</surname><given-names>SM</given-names> </name><name name-style="western"><surname>Chavez</surname><given-names>L</given-names> </name><name name-style="western"><surname>Braciszewski</surname><given-names>JM</given-names> </name><etal/></person-group><article-title>Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems</article-title><source>Addict Sci Clin Pract</source><year>2021</year><month>07</month><day>7</day><volume>16</volume><issue>1</issue><fpage>46</fpage><pub-id pub-id-type="doi">10.1186/s13722-021-00249-3</pub-id><pub-id pub-id-type="medline">34233750</pub-id></nlm-citation></ref><ref id="ref51"><label>51</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>DC</given-names> </name><name name-style="western"><surname>Klimas</surname><given-names>J</given-names> </name><name name-style="western"><surname>Wood</surname><given-names>E</given-names> </name><name name-style="western"><surname>Fairbairn</surname><given-names>N</given-names> </name></person-group><article-title>Medication-assisted treatment for youth with opioid use disorder: current dilemmas and remaining questions</article-title><source>Am J Drug Alcohol Abuse</source><year>2018</year><volume>44</volume><issue>2</issue><fpage>143</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1080/00952990.2017.1399403</pub-id><pub-id pub-id-type="medline">29190156</pub-id></nlm-citation></ref><ref id="ref52"><label>52</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fishman</surname><given-names>M</given-names> </name><name name-style="western"><surname>Wenzel</surname><given-names>K</given-names> </name><name name-style="western"><surname>Scodes</surname><given-names>J</given-names> </name><etal/></person-group><article-title>Young adults have worse outcomes than older adults: secondary analysis of a medication trial for opioid use disorder</article-title><source>J Adolesc Health</source><year>2020</year><month>12</month><volume>67</volume><issue>6</issue><fpage>778</fpage><lpage>785</lpage><pub-id pub-id-type="doi">10.1016/j.jadohealth.2020.07.038</pub-id><pub-id pub-id-type="medline">32873500</pub-id></nlm-citation></ref><ref id="ref53"><label>53</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gustafson</surname><given-names>DH</given-names> </name><name name-style="western"><surname>Landucci</surname><given-names>G</given-names> </name><name name-style="western"><surname>Vjorn</surname><given-names>OJ</given-names> </name><etal/></person-group><article-title>Effects of bundling medication for opioid use disorder with an mHealth intervention targeting addiction: a randomized clinical trial</article-title><source>Am J Psychiatry</source><year>2024</year><month>02</month><day>1</day><volume>181</volume><issue>2</issue><fpage>115</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.20230055</pub-id><pub-id pub-id-type="medline">37789744</pub-id></nlm-citation></ref><ref id="ref54"><label>54</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>King</surname><given-names>VL</given-names> </name><name name-style="western"><surname>Siegel</surname><given-names>G</given-names> </name><name name-style="western"><surname>Priesmeyer</surname><given-names>HR</given-names> </name><name name-style="western"><surname>Siegel</surname><given-names>LH</given-names> </name><name name-style="western"><surname>Potter</surname><given-names>JS</given-names> </name></person-group><article-title>Development and evaluation of a digital app for patient self-management of opioid use disorder: usability, acceptability, and utility study</article-title><source>JMIR Form Res</source><year>2024</year><month>04</month><day>1</day><volume>8</volume><fpage>e48068</fpage><pub-id pub-id-type="doi">10.2196/48068</pub-id><pub-id pub-id-type="medline">38557501</pub-id></nlm-citation></ref><ref id="ref55"><label>55</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nuamah</surname><given-names>J</given-names> </name><name name-style="western"><surname>Mehta</surname><given-names>R</given-names> </name><name name-style="western"><surname>Sasangohar</surname><given-names>F</given-names> </name></person-group><article-title>Technologies for opioid use disorder management: mobile app search and scoping review</article-title><source>JMIR Mhealth Uhealth</source><year>2020</year><month>06</month><day>5</day><volume>8</volume><issue>6</issue><fpage>e15752</fpage><pub-id pub-id-type="doi">10.2196/15752</pub-id><pub-id pub-id-type="medline">32501273</pub-id></nlm-citation></ref><ref id="ref56"><label>56</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schuman-Olivier</surname><given-names>Z</given-names> </name><name name-style="western"><surname>Weiss</surname><given-names>RD</given-names> </name><name name-style="western"><surname>Hoeppner</surname><given-names>BB</given-names> </name><name name-style="western"><surname>Borodovsky</surname><given-names>J</given-names> </name><name name-style="western"><surname>Albanese</surname><given-names>MJ</given-names> </name></person-group><article-title>Emerging adult age status predicts poor buprenorphine treatment retention</article-title><source>J Subst Abuse Treat</source><year>2014</year><month>09</month><volume>47</volume><issue>3</issue><fpage>202</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1016/j.jsat.2014.04.006</pub-id><pub-id pub-id-type="medline">24953168</pub-id></nlm-citation></ref><ref id="ref57"><label>57</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reynolds</surname><given-names>BW</given-names> </name><name name-style="western"><surname>Basso</surname><given-names>MR</given-names> </name><name name-style="western"><surname>Miller</surname><given-names>AK</given-names> </name><name name-style="western"><surname>Whiteside</surname><given-names>DM</given-names> </name><name name-style="western"><surname>Combs</surname><given-names>D</given-names> </name></person-group><article-title>Executive function, impulsivity, and risky behaviors in young adults</article-title><source>Neuropsychology</source><year>2019</year><month>02</month><volume>33</volume><issue>2</issue><fpage>212</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1037/neu0000510</pub-id><pub-id pub-id-type="medline">30589284</pub-id></nlm-citation></ref><ref id="ref58"><label>58</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herczyk</surname><given-names>JM</given-names> </name><name name-style="western"><surname>Zullig</surname><given-names>KJ</given-names> </name><name name-style="western"><surname>Davis</surname><given-names>SM</given-names> </name><etal/></person-group><article-title>Association of loneliness and mindfulness in substance use treatment retention</article-title><source>Int J Environ Res Public Health</source><year>2023</year><month>08</month><day>13</day><volume>20</volume><issue>16</issue><fpage>6571</fpage><pub-id pub-id-type="doi">10.3390/ijerph20166571</pub-id><pub-id pub-id-type="medline">37623157</pub-id></nlm-citation></ref><ref id="ref59"><label>59</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reback</surname><given-names>CJ</given-names> </name><name name-style="western"><surname>R&#x00FC;nger</surname><given-names>D</given-names> </name><name name-style="western"><surname>Fletcher</surname><given-names>JB</given-names> </name><name name-style="western"><surname>Swendeman</surname><given-names>D</given-names> </name></person-group><article-title>Ecological momentary assessments for self-monitoring and counseling to optimize methamphetamine treatment and sexual risk reduction outcomes among gay and bisexual men</article-title><source>J Subst Abuse Treat</source><year>2018</year><month>09</month><volume>92</volume><fpage>17</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.jsat.2018.06.005</pub-id><pub-id pub-id-type="medline">30032940</pub-id></nlm-citation></ref></ref-list></back></article>